Antiphospholipid syndrome
Since the first detailed description of antiphospholipid syndrome (PAS) by Dr. Graham Hughes, this condition is today one of the most frequent autoimmune diseases. The impact of this description has been enormous, as the recognition of individuals with connective tissue diseases requiring anticoagul...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2011
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/21534 |
| Aporte de: |
| Sumario: | Since the first detailed description of antiphospholipid syndrome (PAS) by Dr. Graham Hughes, this condition is today one of the most frequent autoimmune diseases. The impact of this description has been enormous, as the recognition of individuals with connective tissue diseases requiring anticoagulation instead of steroid treatment or with non-steroidal anti-inflammatory drugs has led to a fundamental change in medical practice. |
|---|